A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

NCT06168409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Resistant Hypertension

Interventions

DRUG: Baxdrostat
DRUG: Placebo

Sponsor

AstraZeneca